As syncytia were described in the lungs of COVID-19 patients [29], in vitro cell fusion assays between Spike-expressing cells and ACE2-expressing cells has been described and used for the study of chemical inhibitors of the Spike/ACE2 interaction [30,31,32]. The gene discussed is CHMP5; the disease is COVID-19.